Riskpilot← Back to searchSign inGet full accessPavem AB
ABActiveOrg 5591321020Yngsjövägen 745General medical practice activities · NACE 8621Est. 20170 employees
Revenue 2025
SEK 128K
-10% vs 2024
EBITDA margin
31.5%
+214% vs 2024
Equity ratio
90.1%
Financial strength
Net profit 2025
SEK 37K
+202% vs 2024
| Revenue | SEK 128K | -10% |
| EBITDA | SEK 40K | +214% |
| Net profit | SEK 37K | +202% |
| Total assets | SEK 173K | -14% |
| Equity | SEK 156K | +31% |
| Employees | 0 | — |
Legal name
Pavem AB
Org number
5591321020
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 november 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Läkarkonsult och arbete som kräver medicinsk kunskap. Jakt- friluftsarrangemang samt försäljning och uthyrning av produkter inom denna bransch. Äga och förvalta aktier, lös och fast egendom och därmed förenlig verksamhet.
Address
Yngsjövägen 745
Email
ekelund.philip@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 99 | 302 | 116 | 144 | 128 |
| Staff expenses | — | −26 | −0 | −9 | −5 |
| EBITDA | 17 | 166 | −13 | −35 | 40 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 17 | 166 | −13 | −35 | 40 |
| Net financials | — | — | 0 | −1 | 0 |
| Profit before tax | 17 | 166 | −13 | −36 | 41 |
| Tax | −0 | −31 | — | — | −4 |
| Net profit | 17 | 135 | −13 | −36 | 37 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 42 | 226 | 194 | 201 | 173 |
| Equity | 34 | 168 | 155 | 119 | 156 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 9 | 58 | 39 | 82 | 17 |
| Total debt | 9 | 58 | 39 | 82 | 17 |
EBITDA margin
31.5%
This company
15.8%
Market median
+99% vs market
20212025
Equity ratio
90.1%
This company
38.2%
Market median
+136% vs market
20212025
Return on equity
23.5%
This company
18.4%
Market median
+28% vs market
20212025
Net profit margin
28.5%
This company
8.1%
Market median
+252% vs market
20212025
Asset turnover
0.74×
This company
1.12×
Market median
-34% vs market
20212025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PE Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pavem AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Philip Ekelund | Chief Executive Officer | 0 companies |
| Jennie Elisabeth Ekelund | Deputy Board Member | 0 companies |